Prophylactic use of liposomal amphotericin B in children and adolescents undergoing allogeneic hematopoietic cell transplantation: A 10-years single center experience
Background: Azoles are recommended as antifungal prophylaxis in decreasing the incidence of invasive fungal disease (IFD) in high-risk patients in pediatric oncology, including patients receiving allogeneic hematopoietic cell transplantation (HCT). However, azole related toxicity, pharmacological in...
Saved in:
| Main Authors: | Laura G.Y. Rotte, Coco C.H. de Koning, Yvette G.T. Loeffen, Marc B. Bierings, Jaap Jan Boelens, Caroline A. Lindemans, Tom F.W. Wolfs |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2024-12-01
|
| Series: | EJC Paediatric Oncology |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2772610X24000345 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Comparative efficacy and tolerability of amphotericin B lipid complex and liposomal amphotericin B in the treatment of invasive fungal infections in patients with hematological malignancies: literature review
by: N. V. Dmitrieva, et al.
Published: (2014-07-01) -
Primary treatment of chronic pulmonary aspergillosis with weekly liposomal amphotericin B: A case report from Uganda
by: Winnie Kibone, et al.
Published: (2024-12-01) -
Role of liposomal amphotericin B in intensive care unit: an expert opinion paper
by: Linda Bussini, et al.
Published: (2025-04-01) -
Comparative study of liposomal amphotericin B, posaconazole, and micafungin for primary antifungal prophylaxis in pediatric patients with acute leukemia
by: Anna Sophia Gottschlich, et al.
Published: (2025-08-01) -
Effects of Different Concentrations of AmB on the Unsaturated Phospholipid–Cholesterol Membrane Using the Langmuir Monolayer and Liposome Models
by: Juan Wang, et al.
Published: (2024-11-01)